Titre : The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets.
link : The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets.
The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets.
In case you missed itThe Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets.
Morgan JR, et al. Open Forum Infect Dis. 2018.
Full Text
View Online
Abstract
Background: Direct acting antiviral hepatitis C virus (HCV) therapies are highly effective but costly. Wider adoption of an 8-week ledipasvir/sofosbuvir treatment regimen could result in significant savings, but may be less efficacious compared with a 12-week regimen. We evaluated outcomes under a constrained budget and cost-effectiveness of 8 vs 12 weeks of therapy in treatment-naïve, noncirrhotic, genotype 1 HCV-infected black and nonblack individuals and considered scenarios of IL28B and NS5A resistance testing to determine treatment duration in sensitivity analyses.
Methods: We developed a decision tree to use in conjunction with Monte Carlo simulation to investigate the cost-effectiveness of recommended treatment durations and the population health effect of these strategies given a constrained budget. Outcomes included the total number of individuals treated and attaining sustained virologic response (SVR) given a constrained budget and incremental cost-effectiveness ratios.
Results: We found that treating eligible (treatment-naïve, noncirrhotic, HCV-RNA <6 million copies) individuals with 8 weeks rather than 12 weeks of therapy was cost-effective and allowed for 50% more individuals to attain SVR given a constrained budget among both black and nonblack individuals, and our results suggested that NS5A resistance testing is cost-effective.
Conclusions: Eight-week therapy provides good value, and wider adoption of shorter treatment could allow more individuals to attain SVR on the population level given a constrained budget. This analysis provides an evidence base to justify movement of the 8-week regimen to the preferred regimen list for appropriate patients in the HCV treatment guidelines and suggests expanding that recommendation to black patients in settings where cost and relapse trade-offs are considered.
Thus articles The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets.
that is all articles The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets. This time, hopefully can provide benefits to you all. Okay, see you in another article post.
You are now reading the article The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets. the link address https://newsaninpiration.blogspot.com/2018/01/the-effect-of-shorter-treatment.html
0 Response to "The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets."
Post a Comment